Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 7, Issue 7 (2018)

Lipid nano particulate drug delivery: An overview of the emerging trend

Balamurugan K and Chintamani P
Among the variety of nanoparticles being at present examined by pharmaceutical researchers, lipid nanoparticles have led the pack in view of clear preferences of higher level of biocompatibility and flexibility. Lipid nanoparticles, including solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), lipid-drug conjugates (LDC) and polymer lipid hybrid nanoparticles (PLN), are colloidal carriers with a lipid framework that is solid at body temperature. The execution of lipid nanoparticle plans is extraordinarily affected by their arrangement and structure. The most part made out of lipids, surfactants and co-surfactants are formed the lipid nanoparticles. The lipid materials utilized as a part of the generation of lipid nanoparticles are generally strong at room temperature. Being all around endured in physiological conditions, lipid nanoparticles are ordinarily biocompatible. Fluid lipids, or oils, are particularly utilized for generation of NLCs. Much of the time, lipid nanoparticles are created as scatterings and surface-customized with surfactants to enhance scattering steadiness. Polymers are regularly used to frame polymer-lipid centres in the generation of PLNs. These colloidal carriers have pulled in expanding enthusiasm for their utilization in restorative and corrective applications. Lipid nanoparticles are frequently utilized as managed discharge frameworks, with the structure of the lipid nanoparticles directing their discharge properties. Lipid nano details can be custom-made to meet an extensive variety of item necessities managed by illness condition, course of organization and contemplations of cost, item dependability, harmfulness, adequacy and dosage diminishment. The demonstrated security and viability of lipid-based transporters make them alluring possibility for the plan of pharmaceuticals.
Pages: 779-789  |  1547 Views  626 Downloads

The Pharma Innovation Journal
How to cite this article:
Balamurugan K, Chintamani P. Lipid nano particulate drug delivery: An overview of the emerging trend. Pharma Innovation 2018;7(7):779-789.

Call for book chapter